Sickle Cell Disease (Pediatrics)
Management of Vaso-Occlusive Crisis and Acute Chest Syndrome—Antibiotic and Respiratory Therapy
The use of incentive spirometry in pediatric patients with sickle cell disease to reduce the incidence of acute chest syndrome.
Source: J Pediatr Hematol Oncol 2011;33(6):415-20.
Indexed: PubMed 21792036
Safety of purified poloxamer 188 in sickle cell disease: phase I study of a non-ionic surfactant in the management of acute chest syndrome.
Source: Hemoglobin 2004;28(2):85-102.
Indexed: PubMed 15182051
Beneficial effect of intravenous dexamethasone in children with mild to moderately severe acute chest syndrome complicating sickle cell disease.
Source: Blood 1998;92(9):3082-9.
Indexed: PubMed 9787142
Source: J Pediatr Hematol Oncol 2010;32(3):e91-4.
Indexed: PubMed 20216237
A randomized, placebo-controlled trial of arginine therapy for the treatment of children with sickle cell disease hospitalized with vaso-occlusive pain episodes.
Source: Haematologica 2013;98(9):1375-82.
Indexed: PubMed 23645695
Preliminary assessment of inhaled nitric oxide for acute vaso-occlusive crisis in pediatric patients with sickle cell disease.
Source: JAMA 2003;289(9):1136-42.
Indexed: PubMed 12622584
Source: J Pediatr Hematol Oncol 2002;24(4):279-83.
Indexed: PubMed 11972096